PharVision Advisers »

Enact Hldgs shares owned by PharVision Advisers

Quarter-by-quarter ownership of Enact Hldgs (ACT) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Enact Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Enact Hldgs held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enact Hldgs by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2024-12-31 $248k 7.6k 32.38

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Enact Hldgs

BlackRock
Vanguard Group
Dimensional Fund Advisors
First Trust Advisors
Qube Research & Technologies
Glendon Capital Management
State Street Corporation
Arrowstreet Capital, Limited Partnership
Geode Capital Management
LSV Asset Management
American Century Companies
Bank of New York Mellon
Nuveen
Allianz Asset Management
Prudential Financial

View all funds holding Enact Hldgs